June 25, 2020 -- The Coalition for Epidemic Preparedness Innovations (CEPI) signed an agreement with Italy-based Stevanto Group for the supply of 100 million glass vials to hold up to 2 billion doses of a COVID-19 vaccine.
CEPI has been on the front lines of vaccine development, working on manufacturing issues in parallel to clinical development. The organization has invested over $829 million on nine COVID-19 vaccine candidates with the ultimate goal of developing a successful vaccine in a 12- to 18-month timeframe. This agreement is part of an effort to scale up industrialization to proactively meet global vaccine needs.
Stevanato Group will provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development and a "fast track" access to its glass vial forming lines to CEPI. Image courtesy of Stevanato Group.
Under the agreement, Stevanto Group will supply 100 million type 1 borosilicate glass vials. The vials will be able to hold up to 20 doses per vial. The Stevanto Group will also grant "fast track" access to its glass vial forming lines through its company Spami.
Copyright © 2020 scienceboard.net